To further validate the regulatory activity of ABL1 on TGF-β signaling, endogenous BCR-ABL1 expression was knocked down using two specific siRNAs in BCR-ABL1-positive human leukemia K562 cells. This evidence concerns the gene ABL1 and leukemia.